ADNF-Clustering: An Adaptive and Dynamic Neuro-Fuzzy Clustering for Leukemia Prediction
1 st Marco Aruta University of Naples Federico II Naples, Italy 2 nd Ciro Listone University of Naples Federico II Naples, Italy, 3 rd Giuseppe Murano University of Naples Federico II Naples, Italy 4 th Aniello Murano University of Naples Federico II Naples, Italy · 2025
Read ADNF-Clustering: An Adaptive and Dynamic Neuro-Fuzzy Clustering for Leukemia Prediction by 1 st Marco Aruta University of Naples Federico II Naples, Italy 2 nd Ciro Listone University of Naples Federico II Naples, Italy, 3 rd Giuseppe Murano University of Naples Federico II Naples, Italy 4 th Aniello Murano University of Naples Federico II Naples, Italy (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2506-18396.txt.
Introduction
Marco Aruta and co-authors present ADNF-Clustering in 2025, a learning system for leukemia prediction from cell images. Diagnosis leans on high-volume microscopy, but static clustering cannot follow shifting cell patterns or express doubt in real time. Their framework streams and adapts as data arrives.
A neural feature extractor feeds an online fuzzy clustering engine that starts from soft partitions. A temporal index tracks entropy change to update cluster centers, densities, and fuzziness on the fly. Density-based merging and entropy-guided splitting guard against clumping errors. On a leukemia microscopy data set the tool scored well on cohesion. Label-free running suits a pediatric oncology network, the authors note.
Catalog record
| CREATOR | 1 st Marco Aruta University of Naples Federico II Naples, Italy 2 nd Ciro Listone University of Naples Federico II Naples, Italy, 3 rd Giuseppe Murano University of Naples Federico II Naples, Italy 4 th Aniello Murano University of Naples Federico II Naples, Italy |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2506-18396
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
ADNF-Clustering: An Adaptive and Dynamic Neuro-Fuzzy Clustering for Leukemia Prediction 1 st Marco Aruta University of Naples Federico II Naples, Italy 2 nd Ciro Listone University of Naples Federico II Naples, Italy, 3 rd Giuseppe Murano University of Naples Federico II Naples, Italy 4 th Aniello Murano University of Naples Federico II Naples, Italy Abstract Leukemia diagnosis and monitoring rely increasingly on high‐throughput image data, yet conventional clustering methods lack the flexibility to accommodate evolving cellular patterns and quantify uncertainty in real time. We introduce Adaptive and Dynamic Neuro–Fuzzy Clustering, a novel streaming‐capable framework that marries Convolutional Neural Network based feature extraction with an online fuzzy clustering engine. ADNF initializes soft partitions via Fuzzy C‐Means, then continuously updates micro‐cluster centers, densities, and fuzziness parameters using a Fuzzy Temporal Index (FTI) that measures entropy evolution. A topology-refinement stage performs density-weighted merging and entropy-guided splitting to guard against over (and under) segmentation. On the C‐NMC leukemia microscopy dataset, our tool achieves a silhouette score of 0.51, demonstrating superior cohesion and separation over static baselines. The method’s adaptive uncertainty modeling and label‐free operation hold immediate potential for integration within the INFANT pediatric oncology network, enabling scalable, up‐to‐date support for personalized leukemia management. I Introduction Leukemia is a heterogeneous group of hematological malignancies characterized by uncontrolled proliferation of abnormal white blood cells in bone marrow, peripheral blood and lymphoid tissues. Although the five‑year survival rate has improved substantially over the past decades through advances in chemotherapy, targeted therapies, immunotherapy, radiotherapy and hematopoietic stem cell transplantation (HSCT), leukemia remains a leading cause of cancer‑related mortality worldwide. In 2019 the age‑standardized incidence rate was 8.2 per 100’000 person‑years (down from 9.6 in 1990) and the age‑standardized mortality rate fell to 4.3 per 100’000 (down from 5.8) [ 2 ] . Projections estimate more than 720’000 new cases and 368’000 deaths by 2030, with the greatest burdens in low and middle‑income countries that often lack robust diagnostic infrastructure and affordable access to novel therapies. Leukemia Subtypes and Treatment Modalities The most common clinical subtypes are acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myelogenous leukemia (CML). Genetic predispositions such as Down syndrome or neurofibromatosis and environmental exposures including ionizing radiation further modulate individual risk [ 1 ] . Unlike solid tumours, which can often be addressed by surgical resection, leukemia disseminates systemically and requires whole‐body therapy. Chemotherapy remains the backbone of treatment, efficiently eradicating rapidly dividing blasts but frequently causing off‑target toxicity and drug resistance. Molecularly targeted agents (such as tyrosine kinase inhibitors or monoclonal antibodies) interfere with specific signalling pathways and have improved outcomes in genetically defined subgroups. Immunotherapies, most notably CAR‑T cells directed against CD19 or CD22, can induce durable remissions in refractory cases, although antigen escape and cytokine release syndrome continue to pose significant challenges. Radiotherapy and HSCT offer curative potential for selected patients but demand careful risk–benefit assessment due to substantial toxicity. To enhance efficacy and reduce systemic side effects, a variety of delivery platforms have been engineered, including lipid‑based liposomes (e.g. Vyxeos, Marqibo), PEGylated enzymes (Asparlas, Oncaspar), antibody–drug conjugates (Besponsa, Mylotarg) and biomimetic carriers such as exosomes or peptide scaffolds. Nanoparticles (lipidic, polymeric or inorganic) further permit active targeting via surface ligands or release triggered by tumour microenvironment cues (pH, reactive oxygen species, glutathione), although clinical translation remains limited by stability, batch consistency and clearance considerations [ 4 , 5 ] . I-A Challenges and Unmet Needs Despite these technological advances, key obstacles persist. Therapeutic specificity is often offset by systemic toxicity and variability in antigen expression across patients, restricting the safe dose window. The dynamic nature of leukemia under treatment pressure leads to evolving subclones and relapse, yet static treatment regimens and conventional batch analytics cannot keep pace with real‑time disease shifts. Meanwhile, the explosion of high‑throughput molecular and imaging data outstrips the capacity for expert annotation, which is costly, inconsistent and typically delayed relative to clinical need. Finally, integrating heterogeneous streams (imaging, genomic profiles and clinical metadata) demands flexible, adaptive computational frameworks capable of handling non‑stationary distributions and quantifying uncertainty. These unmet needs underscore the imperative for scalable, label‑efficient analytic pipelines that can continuously assimilate new data, model ambiguity, and uncover latent patterns to guide personalized leukemia management. Our Contributions Despite the fact that fuzzy clustering is very effective in leukemia images, it does not fit well in dynamic and adaptive situations, in which the images are continuously evolving. We created a new algorithm, called Adaptive and Dynamic Neuro Fuzzy Clustering that goes under the acronymous of ADNF clustering. In particular, the proposed methodology holds immediate potential for integration within the INFANT project, a regional initiative aimed at enhancing pediatric oncology care in Campania. The project’s hub-and-spoke network, centered around the Santobono-Pausilipon hospital, provides an ideal framework for future refinement and validation of the model using consolidated local patient data, ultimately contributing to improved diagnostic capabilities across various healthcare contexts. The innovation of this method consists in the implementation of the dynamic part within the fuzzy clustering. Mainly, the fuzzy is useful to capture the transitions between cells, but it does that in a static way. In our project, the fuzzy system acts like an adaptive clustering mechanism that is capable of changing its hyperparameters and thresholds over time. In particular, we extracted the features of the cells using a Convolutional Neural Network (CNN). From this, we obtain the first input for every image: a feature vector X\in\mathbb{R}^{n} . At this point, the fuzzy c‑means algorithm can be applied to the batch to obtain a set of micro‑clusters. For each cluster, the centroid u_{i} is computed and the membership degrees u_{ij} are initially assigned using a fixed value of m. All initial statistics are then calculated, such as number of points, density, timestamp, dynamic threshold \varepsilon_{i} . Then we extract a new vector. At this stage, our dynamic clustering comes into play. Whenever a new data point arrives, we must calculate the distance from the new point X to the centroid of each micro‑cluster u_{i} . Then we assign the point with a certain fuzzy deegree, updating the centroid with the decay parameter \lambda_{t}^{j} . After this, it’s always important to update the density, timestamp and number of points.Before getting into the merging and splitting of the final clusters, we calculated the local fuzzy entropy and the fuzzy transactional index, alias FTI. Related Works Over the past decades, fuzzy clustering has attracted significant attention in data mining and pattern recognition, due to its ability to assign partial membership of samples to multiple clusters rather than enforcing a hard partition [ 3 ] . The most widely used algorithm, Fuzzy C‑Means (FCM), has been applied successfully in medical image segmentation, particularly in hematology and histology, revealing subtle cellular transitions that hard clustering methods often miss [ 6 ] [ 7 ] . However, classical FCM and its static variants are ill‑suited for real‑time data streams, where underlying patterns evolve continuously. To address this limitation, evolving clustering and dynamic fuzzy clustering techniques have been proposed, incorporating incremental updates of cluster centers and membership thresholds in response to new data or shifts in the data distribution. Algorithms based on evolving rules and local density measures adapt to